DEFEROXAMINE POSTTREATMENT REDUCES ISCHEMIC BRAIN INJURY IN NEONATAL RATS
DEFEROXAMINE POSTTREATMENT REDUCES ISCHEMIC BRAIN INJURY IN NEONATAL RATS
复制标题
DOI:
10.1161/01.str.25.5.1039
复制
发表时间:
1994-05-01
期刊:
影响因子:
8.3
通讯作者:
BERO, C
中科院分区:
文献类型:
--
作者:
PALMER, C;ROBERTS, RL;BERO, C
Background and Purpose Iron catalyzes the formation of damaging reactive species during cerebral reperfusion. Brain iron concentration is highest at birth, so the brain of the asphyxiated newborn may be at increased risk of iron-dependent injury. We investigated whether the ferric iron chelator deferoxamine could reduce hypoxic-ischemic brain injury in neonatal rats. Because deferoxamine has concentration-dependent activities other than iron chelation, we measured brain deferoxamine levels and calculated deferoxamine pharmacokinetic parameters.Methods We produced hypoxic-ischemic injury to the right cerebral hemisphere of 7-day-old rats by right common carotid artery ligation followed by 2.25 hours of hypoxia in 8% oxygen. At 5 minutes of recovery from hypoxia the rats received 100 mg/kg deferoxamine mesylate or saline subcutaneously. Rats (saline, n=33; deferoxamine, n=38) were killed at 42 hours of recovery to assess early acute edema by measurement of hemispheric water content. Other rats (saline, n=31; deferoxamine, n=32) were killed at 30 days of age for morphometric determination of right hemisphere atrophy. In still other rats, we measured deferoxamine levels in blood and brain after hypoxia-ischemia.Results Deferoxamine significantly reduced right hemisphere injury as measured by early water content (P